# Discovery of a secreted Bacteroides fragilis mucinase that cleaves mucins with bis-T O-glycans through a carbohydrate binding module-dependent mechanism

**Authors:** Yoshiki Narimatsu, Cayetano Pleguezuelos-Manzano, Daniel Hornikx, Felix Goerdeler, Thapakorn Jaroentomeechai, Katia Flores, Sanae Narimatsu, Charelle Boot, Lars Hansen, Fabien Durbesson, Renaud Vincentelli, Laurie Comstock, Hans Clevers, Victor Taleb, Francisco Corzana, Bernard Henrissat, Henrik Clausen, Ramon Hurtado-Guerrero, Christian Büll

PMC · DOI: 10.1080/19490976.2026.2644983 · 2026-03-19

## TL;DR

Researchers discovered a new mucinase from Bacteroides fragilis that breaks down mucins with specific sugar structures, revealing a mechanism involving carbohydrate-binding modules.

## Contribution

The study identifies nine new mucinases, including a B. fragilis enzyme with a unique glycan preference and a CBM-dependent mechanism.

## Key findings

- Nine CBM-bearing M60-like mucinases were discovered, including a conserved B. fragilis mucinase HC11.
- HC11 and BT4244 show distinct O-glycan preferences, with CBM32 domains essential for cleaving extended mucin substrates.
- B. fragilis secretes HC11 and degrades mucins only after sialic acid removal, suggesting a cooperative CBM-catalytic mechanism.

## Abstract

Degradation of mucins at the host–microbial mucus interphase involves glycosidases that release monosaccharides from O-glycans and mucinases that cleave the mucin protein backbone. Mucinases recognize and cleave peptide bonds at specific sequence motifs with varying O-glycan structures required and/or permissible. Mucinases that digest mucins with intact O-glycans can potentially destroy the protective mucus, while mucinases that only digest mucins with partially degraded O-glycans may serve at a later stage of nutrient sourcing from mucins. Here, we discovered nine CBM-bearing M60-like mucinases across gut commensals and opportunists, including a conserved Bacteroides fragilis mucinase denoted HC11. We also investigated the previously described Bacteroides thetaiotaomicron mucinase BT4244, which together delineates two functional classes with distinct preferences: BT4244 for bis-Tn (GalNAcα1-O-Ser/Thr) and HC11 for bis-T (Galβ1-3GalNAcα1-O-Ser/Thr) O-glycans. Both mucinases harbor carbohydrate-binding modules (CBM32) that bind their cognate O-glycan motifs and are required – together with the catalytic domains – for efficient cleavage of extended mucin domains, which is consistent with cooperative engagement, but are not required for the cleavage of short glycopeptides. We show B. fragilis strains secrete HC11 and degrade mucins only after the removal of sialic acids. Together, these findings expand the mucinase repertoire by nine enzymes spanning commensals and opportunists, demonstrate that CBM32 domains are essential for efficient cleavage of extended mucin substrates likely by promoting multivalent engagement and substrate positioning, and nominateidentify CBM–catalytic cooperation as a mechanism and intervention point for controlling mucus turnover and barrier integrity.

## Linked entities

- **Proteins:** CCL2 (C-C motif chemokine ligand 2)
- **Chemicals:** GalNAc (PubChem CID 35717), Gal (PubChem CID 6036)
- **Species:** Bacteroides fragilis (taxon 817), Bacteroides thetaiotaomicron (taxon 818)

## Full-text entities

- **Genes:** MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, MUC7 (mucin 7, secreted) [NCBI Gene 4589] {aka MG2}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, CYCSP40 (CYCS pseudogene 40) [NCBI Gene 360185] {aka HC7, HCP40}, CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897] {aka MG1, MUC-5B, MUC5, MUC9}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, RSPO1 (R-spondin 1) [NCBI Gene 284654] {aka CRISTIN3, RSPO}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, MUC21 (mucin 21, cell surface associated) [NCBI Gene 394263] {aka C6orf205, KMQK697, MUC-21}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, SELPLG (selectin P ligand) [NCBI Gene 6404] {aka CD162, CLA, PSGL-1, PSGL1}, Mucin [NCBI Gene 100508689], GCNT1 (glucosaminyl (N-acetyl) transferase 1) [NCBI Gene 2650] {aka C2GNT, C2GNT-L, C2GNT1, C2GlcNAcT, G6NT, NACGT2}, CYCSP25 (CYCS pseudogene 25) [NCBI Gene 120528] {aka HC10, HCP25}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}
- **Diseases:** cancer (MESH:D009369), botulism (MESH:D001906), CBMs (MESH:C562602), mucinases (MESH:D002288)
- **Chemicals:** Y-27632 (MESH:C108830), N-acetylcysteine (MESH:D000111), (2(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (MESH:C074712), Glycopeptides (MESH:D006020), SB202190 (MESH:C090942), ammonium bicarbonate (MESH:C027043), erythromycin (MESH:D004917), Tn (MESH:C009497), DIC (MESH:D003606), sialic acids (MESH:D012794), PBA (MESH:C075773), penicillin (MESH:D010406), amino acids (MESH:D000596), Vitamin K1 (MESH:D010837), PBS (MESH:D007854), BD (MESH:C028491), L-Cysteine (MESH:D003545), GlcNAc (MESH:D000117), Silicon (MESH:D012825), oligosaccharides (MESH:D009844), PGE2 (MESH:D015232), carbohydrate (MESH:D002241), CO2 (MESH:D002245), N,N'-diisopropylcarbodiimide (MESH:C081611), H2O (MESH:D014867), isopropanol (MESH:D019840), sugar (MESH:D000073893), gentamycin (MESH:D005839), NH4Cl (MESH:D000643), NaCl (MESH:D012965), glucose (MESH:D005947), Gal (MESH:C101993), Bis-Tris (MESH:C026272), nicotinamide (MESH:D009536), Acetate (MESH:D000085), streptomycin (MESH:D013307), TFA (MESH:D014269), Hemin (MESH:D006427), PVDF (MESH:C024865), Abmole (-), glycolipids (MESH:D006017), T (MESH:D014316), carbon (MESH:D002244), Krypton (MESH:D007726), imidazole (MESH:C029899), PNA (MESH:D020135), IRDye800 (MESH:C427728), O (MESH:D010100), IPTG (MESH:D007544), Kolliphor P 188 (MESH:D020442), bis-T (MESH:C042097), SDS (MESH:D012967), cefoxitin (MESH:D002440), sodium phosphate (MESH:C018279), GlutaMAX (MESH:C054122), monosaccharide (MESH:D009005), A83-01 (MESH:C507011), Fmoc amino acids (MESH:C016456), zinc (MESH:D015032), anhydrotetracycline (MESH:C016229)
- **Species:** Clostridium perfringens (species) [taxon 1502], Rattus norvegicus (brown rat, species) [taxon 10116], Escherichia coli (E. coli, species) [taxon 562], Clostridium botulinum (species) [taxon 1491], Escherichia coli O157:H7 (no rank) [taxon 83334], Bacteroides thetaiotaomicron (species) [taxon 818], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bacteroides fragilis (species) [taxon 817], Akkermansia muciniphila (species) [taxon 239935], Mus musculus (house mouse, species) [taxon 10090], Parabacteroides distasonis (species) [taxon 823], gut metagenome (species) [taxon 749906], Bacteroides fragilis NCTC 9343 (strain) [taxon 272559], Homo sapiens (human, species) [taxon 9606], Bifidobacterium bifidum (species) [taxon 1681]
- **Mutations:** W255A, W171A, Arg285, Thr-Thr, C with 1, E3333655A, R285A, R199A, Ser/Thr, E575A
- **Cell lines:** HEK293 WT — Homo sapiens (Human), Transformed cell line (CVCL_UG81), CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), HC10-19 — Cricetulus griseus (Chinese hamster), Hybrid cell line (CVCL_1K02), ST6GANAC2/3/4 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_H267), NCTC 9343 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_K271), BACON — Homo sapiens (Human), Pyothorax-associated lymphoma, Cancer cell line (CVCL_X749), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), BT4244E575A — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_7941), pKF55 — Homo sapiens (Human), Diabetic retinopathy, Induced pluripotent stem cell (CVCL_B3NU), HEK293-T — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TQ53), B. fragilis O86-5443-2- — Mus musculus (Mouse), Hybridoma (CVCL_A6YM), core1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), C1GALT1 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_SG16), BT4244 — Bos taurus (Bovine), Spontaneously immortalized cell line (CVCL_4134), COSMC — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_S024)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13003899/full.md

---
Source: https://tomesphere.com/paper/PMC13003899